BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 15, 2018
View Archived Issues
Combined delivery of CLN1 gene therapy proven to extend lifespan in INCL mice
Read More
Sienna announces first patient dosed in phase I/II study of SNA-125 for psoriasis
Read More
Bristol-Myers Squibb and Nektar Therapeutics enter global collaboration for NKTR-214
Read More
Sanofi reports pipeline highlights of fourth quarter 2017
Read More
We want your opinion - complete the TRDN user survey
Read More
Meaningful activity seen with BC-819 plus BCG in bladder cancer
Read More
Preliminary results presented for BGB-A317 in patients with urothelial carcinoma
Read More
PICP and MMP-1 identified as biomarkers of Fabry disease cardiomyopathy
Read More
Pfizer's PF-04965842 granted FDA breakthrough therapy designation for atopic dermatitis
Read More
SanBio and Teijin to terminate SB-623 licensing agreement
Read More
Veru presents preclinical data for VERU-111 in prostate cancer models
Read More
Therachon starts first-in-human trial of TA-46 for achondroplasia
Read More
FDA approves Erleada for non-metastatic castration-resistant prostate cancer
Read More
Sumitomo, Nitto announce positive topline results for patch formulation of antipsychotic blonanserin
Read More
EMA grants ATMP classification to Regeneus' Progenza
Read More
Imugene to advance anti-PD-1 mimotope vaccine into preclinical development
Read More
Vectus Biosystems patents compounds for pulmonary fibrosis
Read More
Ginkgo divulges novel HBV antigen secretion inhibitors
Read More
Chengdu Easton Pharmaceutical discloses IP receptor agonists
Read More
Seattle Genetics opens phase I study of SGN-CD48A in multiple myeloma
Read More
Novartis studies LRX-712 in patients with osteoarthritis
Read More
Boehringer Ingelheim Pharma & Co. patents GOAT inhibitors
Read More
New CCR4 antagonists presented by FLX Bio
Read More
Primary endpoint not met in Aramchol study in patients with HIV-associated lipodystrophy and NAFLD
Read More
Oxford BioMedica enters collaboration and license agreement with Bioverativ in hemophilia
Read More
FDA grants de novo request for commercialization of Banyan BTI test for traumatic brain injury
Read More
Santhera licenses POL-6014 from Polyphor
Read More
FDA awards orphan drug designation to selumetinib for neurofibromatosis type 1
Read More